Keyphrases
Heart Failure
100%
Medical Therapy
100%
Patient Perception
100%
Guideline-directed Medical Therapy
71%
Mineralocorticoid Receptor Antagonists
57%
Angiotensin Receptor-neprilysin Inhibitor
57%
Diuretics
42%
Beta-blockers
42%
Angiotensin-converting Enzyme Inhibitor (ACEi)
42%
Angiotensin Receptor Blockers
42%
Living with
28%
Heart Failure Medication
28%
Patients with Heart Failure
14%
Clinical Practice
14%
Patient Education
14%
Effective Strategies
14%
Cardiac Transplantation
14%
Decision-making Process
14%
Medication Use
14%
Adult Population
14%
Online Panel
14%
Decision Support
14%
Design Study
14%
Disease-related
14%
Patient Preference
14%
US Adults
14%
English Speaking
14%
Safety Concerns
14%
Patient-reported Data
14%
Shared Decision Making
14%
Patient Goals
14%
Left Ventricular Assist Device
14%
Screening Questions
14%
High School Education
14%
Patients with Chronic Heart Failure
14%
Initial Surveys
14%
Participant Studies
14%
Nursing and Health Professions
Combination Therapy
100%
Congestive Heart Failure
100%
Practice Guideline
45%
Angiotensin Receptor Antagonist
36%
Mineralocorticoid Antagonist
36%
Enkephalinase Inhibitor
36%
Dipeptidyl Carboxypeptidase Inhibitor
27%
Angiotensin Receptor
27%
Clinical Practice
9%
Shared Decision-Making
9%
Patient Education
9%
Study Participant
9%
Left Ventricular Assist Device
9%
Heart Graft
9%
Diseases
9%
Medicine and Dentistry
Combination Therapy
100%
Congestive Heart Failure
100%
Angiotensin Receptor Antagonist
36%
Mineralocorticoid Antagonist
36%
Enkephalinase Inhibitor
36%
ACE Inhibitor
27%
Angiotensin Receptor
27%
Diuretics
27%
Decision Making
9%
Study Participant
9%
Shared Decision Making
9%
Awareness
9%
Left Ventricular Assist Device
9%
Heart Graft
9%
Diseases
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Combination Therapy
100%
Mineralocorticoid Antagonist
36%
Angiotensin Receptor Antagonist
36%
Enkephalinase Inhibitor
36%
Dipeptidyl Carboxypeptidase Inhibitor
27%
Angiotensin Receptor
27%
Diuretics
27%
Diseases
9%